Skip to Content
  • Bonne Chance, Brandicourt

    Sanofi’s CEO hunt has ended, and the roue de la fortune has pointed to Bayer’s Olivier Brandicourt. (I’m tempted to keep dropping French phras… Read More
  • Layoffs at Boehringer Ingelheim

    According to FierceBiotech, Boehinger is cutting staff in Ridgefield, CT. They are, they say, “in the process of rebalancing its workforce in the U.S. to… Read More
  • AstraZeneca’s Anti-Infective Woes

    According to Fierce Pharma, AstraZeneca is having trouble unloading its anti-infectives division. Part of the problem seems to be that they’re trying to s… Read More
  • A Trick Question

    I got a kick out of this FierceBiotech story on Pfizer and Ian Read, based on this talk with him. Pfizer probably won’t be building up the innovative side… Read More
  • Layoffs at Sanofi

    As foretold by a comment around here the other day, Sanofi seems to indeed have had the dreaded mandatory-attendance business meeting today, and I’m heari… Read More
  • Crowdfunding a Stem Cell Company

    Crowdfunding is a hot idea in small biopharma, but a lot of people don’t quite know what to make of it. I’ve written about some academic examples of… Read More
  • Ian Read’s Pfizer Coin

    Via Matthew Herper on Twitter, I see that the Telegraph has this insight into Pfizer’s corporate culture, or at least its upper reaches. CEO Ian Read appa… Read More
  • Sanofi’s Search

    Have you noticed that Sanofi hasn’t named a replacement yet for their ousted CEO Chris Viehbacher? It doesn’t seem to be for lack of trying. Stories… Read More
Page 20 of 104« First...10...1819202122...304050...Last »